|
US2616927A
(en)
|
1950-05-12 |
1952-11-04 |
Minnesota Mining & Mfg |
Fluorocarbon tertiary amines
|
|
US4452818A
(en)
|
1982-03-19 |
1984-06-05 |
Haidt Sterling J |
Extraocular method of treating the eye with liquid perfluorocarbons
|
|
US5077036A
(en)
|
1986-01-14 |
1991-12-31 |
Alliance Pharmaceutical Corp. |
Biocompatible stable fluorocarbon emulsions for contrast enhancement and oxygen transport comprising 40-125% wt./volume fluorocarbon combined with a phospholipid
|
|
US5518731A
(en)
|
1990-09-27 |
1996-05-21 |
Allergan, Inc. |
Nonaqueous fluorinated drug delivery vehicle suspensions
|
|
US6458376B1
(en)
|
1990-09-27 |
2002-10-01 |
Allergan, Inc. |
Nonaqueous fluorinated drug delivery suspensions
|
|
US5326566A
(en)
|
1991-05-17 |
1994-07-05 |
Bristol-Myers Squibb Company |
Use of dibutyl adipate and isopropyl myristate in topical and transdermal products
|
|
FR2679150A1
(fr)
|
1991-07-17 |
1993-01-22 |
Atta |
Preparations comprenant un fluorocarbure ou compose hautement fluore et un compose organique lipophile-fluorophile, et leurs utilisations.
|
|
US6602900B2
(en)
|
1992-09-21 |
2003-08-05 |
Allergan, Inc. |
Cyclopentane heptan(ENE)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
|
|
US5336175A
(en)
|
1992-10-29 |
1994-08-09 |
Mames Robert N |
Method for the treatment of retinal detachments
|
|
US5370313A
(en)
|
1994-01-10 |
1994-12-06 |
Beard; Walter C. |
Sterile liquid dispenser
|
|
FR2720943B1
(fr)
|
1994-06-09 |
1996-08-23 |
Applic Transferts Technolo |
Emulsions inverses stables à forte concentration en composé(s) fluoré(s) et leur utilisation pour l'administration pulmonaire de médicaments et pour la fabrication d'émulsions multiples.
|
|
US6294563B1
(en)
|
1994-10-27 |
2001-09-25 |
Allergan Sales, Inc. |
Combinations of prostaglandins and brimonidine or derivatives thereof
|
|
US5696164A
(en)
|
1994-12-22 |
1997-12-09 |
Johnson & Johnson Consumer Products, Inc. |
Antifungal treatment of nails
|
|
US5667809A
(en)
|
1995-06-07 |
1997-09-16 |
Alliance Pharmaceutical Corp. |
Continuous fluorochemical microdispersions for the delivery of lipophilic pharmaceutical agents
|
|
US5874481A
(en)
|
1995-06-07 |
1999-02-23 |
Alliance Pharmaceutical Corp. |
Fluorochemical solutions for the delivery of lipophilic pharmaceutical agents
|
|
US5578020A
(en)
|
1995-09-01 |
1996-11-26 |
Mosley; Manuel L. |
Drop dispensing apparatus
|
|
DE19536504C2
(de)
|
1995-09-29 |
1999-09-23 |
H Meinert |
Verwendung fluorierter Alkane
|
|
US5874469A
(en)
|
1996-01-05 |
1999-02-23 |
Alcon Laboratories, Inc. |
Fluoroalkyl hydrocarbons for administering water insoluble or unstable drugs
|
|
US5863560A
(en)
|
1996-09-11 |
1999-01-26 |
Virotex Corporation |
Compositions and methods for topical application of therapeutic agents
|
|
IN184589B
(https=)
|
1996-10-16 |
2000-09-09 |
Alza Corp |
|
|
DE19709704C2
(de)
|
1997-03-10 |
1999-11-04 |
Michael Georgieff |
Verwendung einer flüssigen Präparation von Xenon zur intravenösen Verabreichung bei Einleitung und/oder Aufrechterhaltung der Anaesthesie
|
|
US5980936A
(en)
|
1997-08-07 |
1999-11-09 |
Alliance Pharmaceutical Corp. |
Multiple emulsions comprising a hydrophobic continuous phase
|
|
US6335335B2
(en)
|
1997-11-05 |
2002-01-01 |
Senju Pharmaceutical Co., Ltd. |
Prolonged-action eye drop
|
|
US5981607A
(en)
|
1998-01-20 |
1999-11-09 |
Allergan |
Emulsion eye drop for alleviation of dry eye related symptoms in dry eye patients and/or contact lens wearers
|
|
CA2278328C
(en)
|
1998-02-09 |
2008-07-22 |
Macrochem Corporation |
Antifungal nail lacquer and method using same
|
|
DE19861012A1
(de)
|
1998-03-18 |
1999-09-30 |
Pharm Pur Gmbh |
Behandlungsmittel für die Ophthalmologie
|
|
DE69912441T2
(de)
|
1998-08-19 |
2004-08-19 |
Skyepharma Canada Inc., Verdun |
Injizierbare wässerige propofoldispersionen
|
|
US6140374A
(en)
|
1998-10-23 |
2000-10-31 |
Abbott Laboratories |
Propofol composition
|
|
US6159977A
(en)
|
1998-11-16 |
2000-12-12 |
Astan, Inc. |
Therapeutic anti-fungal nail preparation
|
|
US7258869B1
(en)
|
1999-02-08 |
2007-08-21 |
Alza Corporation |
Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle
|
|
US6177477B1
(en)
|
1999-03-24 |
2001-01-23 |
American Home Products Corporation |
Propofol formulation containing TRIS
|
|
US6239113B1
(en)
|
1999-03-31 |
2001-05-29 |
Insite Vision, Incorporated |
Topical treatment or prevention of ocular infections
|
|
DE19926890C1
(de)
|
1999-06-12 |
2000-07-27 |
Pharm Pur Gmbh |
Verwendung eines hochfluorierten oligomeren Alkans in der Ophthalmologie
|
|
DE19938668B4
(de)
|
1999-08-14 |
2006-01-26 |
Bausch & Lomb Inc. |
Tränenersatzmittel
|
|
US6528086B2
(en)
|
1999-09-28 |
2003-03-04 |
Zars, Inc. |
Methods and apparatus for drug delivery involving phase changing formulations
|
|
US20030018044A1
(en)
|
2000-02-18 |
2003-01-23 |
Peyman Gholam A. |
Treatment of ocular disease
|
|
DE10024413A1
(de)
|
2000-05-19 |
2001-12-06 |
Mika Pharma Gmbh |
Pharmazeutische und/oder kosmetische Zubereitung
|
|
DE10042412B4
(de)
|
2000-08-30 |
2005-12-22 |
Lts Lohmann Therapie-Systeme Ag |
Transdermales therapeutisches System zur Abgabe von Venlafaxin, und seine Verwendung
|
|
US6399087B1
(en)
|
2000-12-20 |
2002-06-04 |
Amphastar Pharmaceuticals, Inc. |
Propofol formulation with enhanced microbial inhibition
|
|
CA2446060A1
(en)
|
2001-05-07 |
2002-11-14 |
Corium International |
Compositions and delivery systems for administration of a local anesthetic agent
|
|
TWI298257B
(en)
*
|
2001-05-31 |
2008-07-01 |
Allergan Inc |
Hypotensive lipid and timolol compositions and methods of using same
|
|
CZ301310B6
(cs)
|
2001-09-04 |
2010-01-13 |
Trommsdorff Gmbh & Co. Kg Arzneimittel |
Náplast
|
|
US7030149B2
(en)
*
|
2002-04-19 |
2006-04-18 |
Allergan, Inc. |
Combination of brimonidine timolol for topical ophthalmic use
|
|
CA2481394A1
(en)
*
|
2002-05-24 |
2003-12-04 |
Dr. Gerhard Mann Chem.-Pharm. Fabrik Gmbh |
Drop-forming ophthalmic gel preparation comprising diclofenamide and timolol
|
|
US20040033228A1
(en)
|
2002-08-16 |
2004-02-19 |
Hans-Juergen Krause |
Formulation of human antibodies for treating TNF-alpha associated disorders
|
|
US7074827B2
(en)
|
2002-10-24 |
2006-07-11 |
Sucampo Ag (Usa) Inc. |
Method for treating ocular hypertension and glaucoma
|
|
EP2977043A3
(en)
|
2003-08-25 |
2016-04-06 |
Foamix Pharmaceuticals Ltd. |
Penetrating pharmaceutical foam
|
|
US20050079210A1
(en)
|
2003-10-09 |
2005-04-14 |
Gupta Shyam K. |
Liposomal delivery system for topical pharmaceutical, cosmeceutical, and cosmetic ingredients
|
|
ATE534373T1
(de)
|
2003-10-10 |
2011-12-15 |
Antares Pharma Ipl Ag |
Transdermale pharmazeutische formulierung zur minimierung von rückständen auf der haut
|
|
JP2007511616A
(ja)
|
2003-11-19 |
2007-05-10 |
バーンズ−ジューイッシュ ホスピタル |
増強された薬物送達
|
|
GB0408164D0
(en)
|
2004-04-13 |
2004-05-19 |
Immune Targeting Systems Ltd |
Antigen delivery vectors and constructs
|
|
WO2005099718A1
(en)
|
2004-04-19 |
2005-10-27 |
Centre National De La Recherche Scientifique (C.N.R.S.) |
Lung surfactant supplements
|
|
MXPA06014425A
(es)
|
2004-06-08 |
2007-05-23 |
Ocularis Pharma Inc |
Composiciones oftalmicas hidrofobas y metodo de uso.
|
|
US7063241B2
(en)
|
2004-06-10 |
2006-06-20 |
Allergan, Inc. |
Dispensing tip
|
|
AU2005262392A1
(en)
|
2004-07-01 |
2006-01-19 |
Johnson & Johnson Vision Care, Inc. |
Compositions and methods for treating eye disorders and conditions
|
|
CN101048136B
(zh)
*
|
2004-08-31 |
2011-06-22 |
施蒂福研究澳大利亚股份有限公司 |
微乳化和亚微米乳化方法和组合物
|
|
US20060078580A1
(en)
|
2004-10-08 |
2006-04-13 |
Mediquest Therapeutics, Inc. |
Organo-gel formulations for therapeutic applications
|
|
US7740875B2
(en)
|
2004-10-08 |
2010-06-22 |
Mediquest Therapeutics, Inc. |
Organo-gel formulations for therapeutic applications
|
|
EP1688161A1
(en)
|
2004-11-02 |
2006-08-09 |
Switch Biotech Aktiengesellschaft |
Use of pirlindole for the treatment of diseases which are characterized by proliferation of t-lymphocytes and/or hyperproliferation of keratinocytes in particular atopic dermatitis and psoriasis
|
|
US7851504B2
(en)
|
2005-03-16 |
2010-12-14 |
Allergan, Inc. |
Enhanced bimatoprost ophthalmic solution
|
|
GB0511499D0
(en)
|
2005-06-06 |
2005-07-13 |
Medpharm Ltd |
Topical ungual formulations
|
|
ATE420625T1
(de)
|
2005-08-05 |
2009-01-15 |
Bharat Serums & Vaccines Ltd |
Intravenöse propofol-emulsionszusammensetzungen mit konservierendem effekt
|
|
FR2892023B1
(fr)
|
2005-10-14 |
2009-09-25 |
Galderma Sa |
Composition pharmaceutique a base d'amorolfine et d'agent filmogene hydrosoluble pour application ungueale et peri-ungueale
|
|
DE102005050431A1
(de)
|
2005-10-21 |
2007-04-26 |
Lts Lohmann Therapie-Systeme Ag |
Transdermales therapeutisches System zur Verabreicherung lipophiler und/oder wenig hautpermeabler Wirkstoffe
|
|
DE102005055811A1
(de)
|
2005-11-23 |
2007-05-31 |
Novaliq Gmbh |
Verwendung einer Zusammensetzung zur Konservierung von Organen und Gliedmaßen
|
|
TWI376239B
(en)
|
2006-02-01 |
2012-11-11 |
Andrew Xian Chen |
Vitamin e succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof
|
|
US20070238732A1
(en)
*
|
2006-04-10 |
2007-10-11 |
Allergan, Inc. |
Brimonidine and timolol compositions
|
|
EP2070518A2
(en)
|
2006-07-25 |
2009-06-17 |
Osmotica Corp. |
Ophthalmic solutions
|
|
EP2068828A2
(en)
|
2006-09-29 |
2009-06-17 |
SurModics, Inc. |
Biodegradable ocular implants and methods for treating ocular conditions
|
|
EP2099408B1
(en)
|
2006-11-28 |
2016-10-05 |
Wisconsin Alumni Research Foundation |
Fluoropolymer-based emulsions for the intravenous delivery of fluorinated volatile anesthetics
|
|
AU2007330356B2
(en)
|
2006-12-07 |
2013-05-02 |
Sun Pharma Advanced Research Company Ltd |
Metered drop bottle for dispensing microliter amounts of a liquid in the form of a drop
|
|
ITMI20070890A1
(it)
|
2007-05-04 |
2008-11-05 |
Sifi Spa |
Composizioni oftalmiche per il trattamento della ipertensione oculare e del glaucoma
|
|
US8492334B2
(en)
*
|
2007-06-21 |
2013-07-23 |
Yale University |
Sustained intraocular delivery of drugs from biodegradable polymeric microparticles
|
|
FR2918891B1
(fr)
|
2007-07-20 |
2009-09-25 |
Thea Sa Lab |
Solution ophtalmique a base de prostaglandines sans conservateur
|
|
US8222292B2
(en)
|
2007-08-06 |
2012-07-17 |
Insys Therapeutics, Inc. |
Liquid cannabinoid formulations
|
|
DE102007055046A1
(de)
|
2007-11-19 |
2009-05-28 |
Fluoron Gmbh |
Infusionslösung
|
|
ES2377152T3
(es)
|
2008-04-18 |
2012-03-22 |
Novaliq Gmbh |
Uso inhalativo e instilativo de alcanos semifluorados como vehículos de principios activos en la región intrapulmonar
|
|
US20100006600A1
(en)
|
2008-07-14 |
2010-01-14 |
Dascanio Gustavo A |
Fluid dispenser including hydrophobic ring
|
|
HUE032158T2
(en)
|
2008-10-31 |
2017-09-28 |
Univ Mississippi |
Process for the preparation of delta9-THC amino acid esters
|
|
US20100189765A1
(en)
|
2008-11-26 |
2010-07-29 |
Erickson Signe R |
Implantable ocular drug delivery device and methods
|
|
US8501800B2
(en)
|
2009-03-05 |
2013-08-06 |
Insite Vision Incorporated |
Controlled-release ophthalmic vehicles
|
|
IT1393419B1
(it)
|
2009-03-19 |
2012-04-20 |
Medivis S R L |
Composizioni oftalmiche a base di acidi grassi polinsaturi omega-3 e omega-6.
|
|
WO2010146536A1
(en)
|
2009-06-18 |
2010-12-23 |
Koninklijke Philips Electronics N.V. |
Suspension of particles with drug
|
|
US9012503B2
(en)
|
2009-06-25 |
2015-04-21 |
Lion Corporation |
Ophthalmic composition
|
|
EP2387391B1
(de)
|
2009-07-24 |
2017-01-11 |
MIKA Pharma Gesellschaft für die Entwicklung und Vermarktung pharmazeutischer Produkte mbH |
Verfahren zur entwicklung einer als schaum auf die haut zu applizierenden flüssigen zusammensetzung sowie eine topisch applizierbare zusammensetzung
|
|
EP2332525A1
(en)
|
2009-11-23 |
2011-06-15 |
Novaliq GmbH |
Pharmaceutical composition comprising propofol
|
|
EP2335735A1
(en)
|
2009-12-14 |
2011-06-22 |
Novaliq GmbH |
Pharmaceutical composition for treatment of dry eye syndrome
|
|
US20110223208A1
(en)
|
2010-03-09 |
2011-09-15 |
Beth Hill |
Non-Aqueous High Concentration Reduced Viscosity Suspension Formulations
|
|
CA2792517C
(en)
|
2010-03-09 |
2020-03-24 |
Janssen Biotech, Inc. |
Non-aqueous high concentration reduced viscosity suspension formulations
|
|
PL2547323T3
(pl)
|
2010-03-17 |
2016-07-29 |
Novaliq Gmbh |
Kompozycja farmaceutyczna do leczenia podwyższonego ciśnienia wewnątrzgałkowego
|
|
DE102010022567A1
(de)
|
2010-06-02 |
2011-12-08 |
Fluoron Gmbh |
Zubereitung
|
|
EP2444063A1
(en)
*
|
2010-10-20 |
2012-04-25 |
Novaliq GmbH |
Liquid pharmaceutical compositions for the delivery of active ingredients
|
|
EP2462921A1
(en)
*
|
2010-11-11 |
2012-06-13 |
Novaliq GmbH |
Liquid pharmaceutical compositions for the treatment of a posterior eye disease
|
|
ES2711760T3
(es)
|
2011-01-04 |
2019-05-07 |
Novaliq Gmbh |
Emulsiones de aceite/agua que comprenden alcanos semifluorados
|
|
DK2714010T3
(en)
|
2011-05-25 |
2017-06-12 |
Novaliq Gmbh |
TOPICAL PHARMACEUTICAL COMPOSITION BASED ON SEMIFLUORED ALKANES
|
|
JP6023181B2
(ja)
|
2011-05-25 |
2016-11-09 |
ノバリック ゲーエムベーハー |
爪に投与するための医薬組成物
|
|
JP2012250951A
(ja)
*
|
2011-06-06 |
2012-12-20 |
Santen Pharmaceut Co Ltd |
アデノシン誘導体とプロスタグランジン類とβ受容体遮断薬の組合せ剤
|
|
US8758826B2
(en)
|
2011-07-05 |
2014-06-24 |
Wet Inc. |
Cannabinoid receptor binding agents, compositions, and methods
|
|
KR101989648B1
(ko)
|
2012-01-23 |
2019-06-14 |
노바리크 게엠베하 |
부분불소화 알칸에 기초한 안정화된 단백질 조성물
|
|
US9549966B2
(en)
|
2012-02-21 |
2017-01-24 |
Massachusetts Eye & Ear Infirmary |
Inflammatory eye disorders
|
|
US9878000B2
(en)
|
2012-06-20 |
2018-01-30 |
University Of Waterloo |
Mucoadhesive nanoparticle composition comprising immunosuppresant and methods of use thereof
|
|
AU2013314303B2
(en)
|
2012-09-12 |
2018-01-18 |
Novaliq Gmbh |
Semifluorinated alkane compositions
|
|
CN113679699B
(zh)
|
2012-09-12 |
2022-10-28 |
诺瓦利克有限责任公司 |
包含半氟化烷烃的混合物的组合物
|
|
DK2708228T3
(en)
|
2012-09-12 |
2018-08-20 |
Novaliq Gmbh |
COMPOSITION FOR EYE RINSE
|
|
TW201427989A
(zh)
|
2012-12-18 |
2014-07-16 |
Novartis Ag |
長效性蛋白質之組合物及方法
|
|
EP2783703A1
(en)
|
2013-03-25 |
2014-10-01 |
B. Braun Melsungen AG |
Semifluorocarbon compound containing contrast agent
|
|
PT3024484T
(pt)
|
2013-07-23 |
2018-10-24 |
Novaliq Gmbh |
Composições de anticorpo estabilizadas
|
|
FR3013977A1
(fr)
|
2013-12-03 |
2015-06-05 |
Oreal |
Composition cosmetique comprenant des filtres uv
|
|
WO2015153469A1
(en)
|
2014-03-31 |
2015-10-08 |
Amcor Limited |
Controlled release container
|
|
EP2944324A1
(de)
|
2014-05-13 |
2015-11-18 |
LTS LOHMANN Therapie-Systeme AG |
Verwendung von semifluorierten Alkanen in transdermalen therapeutischen Systemen
|
|
CN106572941B
(zh)
|
2014-08-13 |
2020-06-23 |
佛罗里达大学研究基金会股份有限公司 |
从眼药水中去除防腐剂
|
|
EP3209331B1
(en)
*
|
2014-10-20 |
2023-07-12 |
Sentiss Pharma Private Limited |
Ophthalmic solution
|
|
WO2016082644A1
(en)
*
|
2014-11-26 |
2016-06-02 |
The University Of Hong Kong |
A semifluorinated alkane based cleaner for removing emulsified droplets in the eye to reduce the complications associated with the emulsification of silicone oil
|
|
CN110403923B
(zh)
|
2015-09-30 |
2021-09-21 |
诺瓦利克有限责任公司 |
半氟化化合物和其组合物
|
|
US11154513B2
(en)
|
2015-09-30 |
2021-10-26 |
Novaliq Gmbh |
Semifluorinated compounds
|
|
EP3463344A4
(en)
|
2016-06-01 |
2020-02-12 |
Harold Richard Hellstrom |
TREATMENT OF DRY EYE WITH PARASYMPATHIC AND ANTISYMPATHIC AGENTS
|
|
PT3442480T
(pt)
*
|
2016-06-23 |
2019-12-23 |
Novaliq Gmbh |
Método de administração tópica
|
|
WO2018033854A1
(en)
|
2016-08-15 |
2018-02-22 |
Santen Pharmaceutical Co., Ltd. |
Ophthalmic composition and a method for treating ocular hypertension and glaucoma
|
|
CA3036297C
(en)
|
2016-09-22 |
2023-09-05 |
Novaliq Gmbh |
Pharmaceutical compositions for use in the therapy of blepharitis
|
|
WO2018055101A1
(en)
|
2016-09-23 |
2018-03-29 |
Novaliq Gmbh |
Ophthalmic compositions comprising ciclosporin
|
|
AU2017333420A1
(en)
|
2016-09-28 |
2019-04-04 |
Novaliq Gmbh |
Compositions comprising a cannabinoid receptor binding ligand
|
|
BR112019012568A2
(pt)
|
2016-12-22 |
2019-11-26 |
Novaliq Gmbh |
composições compreendendo tacrolimus para o tratamento de doenças intraoculares inflamatórias
|
|
EP4374851B1
(en)
|
2016-12-23 |
2026-04-15 |
Novaliq GmbH |
Ophthalmic composition for treatment of dry eye disease
|
|
CA3058097C
(en)
|
2017-04-21 |
2024-01-02 |
Novaliq Gmbh |
Iodine compositions
|
|
WO2018206386A1
(en)
|
2017-05-06 |
2018-11-15 |
Novaliq Gmbh |
Drop dispenser
|
|
US11278503B2
(en)
|
2017-05-12 |
2022-03-22 |
Novaliq Gmbh |
Pharmaceutical compositions comprising semifluorinated alkanes for the treatment of contact lense-related conditions
|
|
MX2020003534A
(es)
|
2017-09-27 |
2020-07-29 |
Novaliq Gmbh |
Composiciones oftalmicas que comprenden latanoprost para usarse en el tratamiento de las enfermedades oculares.
|
|
WO2019068763A1
(en)
|
2017-10-04 |
2019-04-11 |
Novaliq Gmbh |
OPHTHALMIC COMPOSITIONS COMPRISING F6H8
|
|
KR20200128407A
(ko)
|
2018-03-02 |
2020-11-12 |
노바리크 게엠베하 |
네비볼롤을 포함하는 약제학적 조성물
|
|
SG11202007860XA
(en)
*
|
2018-03-28 |
2020-09-29 |
Novaliq Gmbh |
Pharmaceutical composition comprising timolol
|
|
CN112153970A
(zh)
|
2018-04-27 |
2020-12-29 |
诺瓦利克有限责任公司 |
用于治疗青光眼的包含他氟前列素的眼用组合物
|
|
WO2020058504A1
(en)
|
2018-09-22 |
2020-03-26 |
Novaliq Gmbh |
Ophthalmic compositions for treatment of ocular surface damage and symptoms of dryness
|
|
SG11202102820VA
(en)
|
2018-10-12 |
2021-04-29 |
Novaliq Gmbh |
Ophthalmic composition for treatment of dry eye disease
|
|
ES2989413T3
(es)
|
2018-11-27 |
2024-11-26 |
Novaliq Gmbh |
Composiciones de alcanos semifluorados que comprenden ésteres etílicos de ácidos grasos omega-3
|
|
WO2020152046A1
(en)
|
2019-01-21 |
2020-07-30 |
Novaliq Gmbh |
Pharmaceutical composition for the treatment of ocular neovascularisation
|
|
EP3923907B1
(en)
|
2019-02-13 |
2024-09-25 |
Novaliq GmbH |
Compositions and methods for the treatment of ocular neovascularization
|
|
WO2020239646A1
(en)
|
2019-05-24 |
2020-12-03 |
Novaliq Gmbh |
Ophthalmic composition for the treatment of ocular allergy
|
|
JP2022543402A
(ja)
|
2019-08-09 |
2022-10-12 |
ノバリック ゲーエムベーハー |
プロスタグランジンアナログを含む局所組成物
|
|
KR20220058577A
(ko)
|
2019-09-06 |
2022-05-09 |
노바리크 게엠베하 |
포도막염 치료를 위한 안과용 조성물
|